Navigation Links
Utilizing Immunosequencing in Immuno-Oncology and Immunotherapy Research, Upcoming Webinar Hosted by Xtalks
Date:11/2/2019

Join Patrick Raber, PhD, Manager, Research and Business Development at Adaptive Biotechnologies in a live webinar on Friday, November 15, 2019 at 1pm EST to learn about immunoSEQ Technology and its application in immuno-oncology.

Immunosequencing, the science of profiling T-cell receptors (TCRs) and B-cell receptors (BCRs), has been widely utilized to understand how the immune system changes in various disease states and how various treatment modalities impact immune responses. This webinar aims to provide an overview of Adaptive Biotechnologies’ immunoSEQ® Technology and cloud-based software, immunoSEQ Analyzer®. The webinar will cover functions of the Analyzer software and demonstrate how immunosequencing data can be incorporated into preclinical and clinical research with a focus on immuno-oncology and immunotherapy.

Other topics of discussion include:

  • Specific examples of how immunoSEQ was used to assess repertoire properties in pre-treatment tumor biopsies and how those findings were correlated with survival and response to checkpoint blockade
  • How the Analyzer software can identify individual clones and track those clones in longitudinal samples
  • Overview of data on patients who demonstrated adverse events in response to immunotherapy treatment and the repertoire properties associated with those toxicities
  • How immunosequencing may be used to identify dominant clones in cellular infusion products, along with appropriate sequencing strategies for monitoring
  • Overview of Adaptive’s immuneACCESS® portal, a free, online database containing thousands of samples worth of human and murine data that can be easily analyzed and incorporated into existing or future immunoSEQ projects

For more information or to register for this event, visit Utilizing Immunosequencing in Immuno-Oncology and Immunotherapy Research.

immunoSEQ is Research Use Only. Not for use in diagnostic procedures.

ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com.
For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/.

Contact:
Candice Tang
Tel: +1 (416) 977-6555 ext 400
Email: ctang@xtalks.com

Read the full story at https://www.prweb.com/releases/utilizing_immunosequencing_in_immuno_oncology_and_immunotherapy_research_upcoming_webinar_hosted_by_xtalks/prweb16686087.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Boston Strategic Partners, Inc. is Utilizing Electronic Health Record Data to Analyze Hospital Treated Pneumonia
2. Boston Strategic Partners, Inc. is utilizing Electronic Health Record Data for real world data analysis
3. DiaSorin Showcases the Benefits of Utilizing Available Biomarkers to Tailor and Individualize Therapy in Diabetes
4. MediVet Biologics Completes Initial Cancer Trial Utilizing Immunotherapy
5. Molecular Health Gains Patent for Novel Receptor Utilizing Computational Biomarker Discovery Technology
6. Leading Biotech Companies Seek Biologic Treatments for Rare Diseases Utilizing Viable Therapeutic Approach - Company Receives FDA Orphan Drug Designation for Bryostatin
7. Introducing a Personal Injury Chiropractor in Tampa Florida That is Utilizing the Latest Treatment Technology in the Industry, Courtesy of Elan Wellness Center
8. Study Scavenger and JALR.org Announce Alliance Utilizing Smart Phone Capabilities to Bring Clinical Trials to Motivated Subjects
9. Adaptive Biotechnologies and Collaborators Present 16 Studies Demonstrating Clinical Significance of ImmunoSequencing at 55th Annual Meeting of the American Society for Hematology
10. Immuno-Oncology 360° Summit Confirms Program Line-up for February 7-9, 2018
11. The Trout Group and The Conference Forum Announce Immuno-Oncology 360° Partnership to Fight a Wider Range of Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/12/2019)... ... November 12, 2019 , ... ... the food and beverage industry launched a new innovative website. , After extensive ... Now, the website offers global visitors updated ingredient usage tables by food application ...
(Date:11/6/2019)... ... ... Diversified Technologies, Inc. has introduced a PEF production system for ... processing. , The DTI Industrial PEF Unit can pre-treat whole pieces of fruits and ... up to 50% and achieve up to an 80% reduction of drying energy. ...
(Date:11/5/2019)... ... ... was demonstrating signs of osteoarthritis in April 2019. He was lame and stiff and ... play were normal, it was clear that he was in pain. , Ole’s owner took ... Center in San Diego, California. Dr. Mullen is an experienced VetStem user and ...
(Date:10/30/2019)... ... October 30, 2019 , ... While using cold plasma to kill cancer cells ... Dakota School of Mines & Technology are exploring new ways to regulate cold ... , If successful, the technique would prove to be a drug-free, minimally invasive cancer ...
Breaking Biology Technology:
(Date:11/5/2019)... , ... November 05, 2019 , ... ... manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced ... at Hotel Sofia, Barcelona, Spain on Nov. 12 – 14, 2019. , On ...
(Date:10/30/2019)... Va. (PRWEB) , ... October 30, 2019 , ... ... offering from the Farm Credit Knowledge Center in which participants will learn about ... industry best practice relating to these technologies. , Participants will have the ...
(Date:10/29/2019)... ... October 29, 2019 , ... ... announced that Octapharma, one of the world’s largest human protein manufacturers, has ... manufacturing of therapeutic proteins addressing severe diseases in the areas of haematology, ...
Breaking Biology News(10 mins):